{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T06:20:10Z","timestamp":1783664410688,"version":"3.55.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T00:00:00Z","timestamp":1732838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T00:00:00Z","timestamp":1732838400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-81458-z","type":"journal-article","created":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T02:30:19Z","timestamp":1732847419000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Impact of natremia on metastatic non small cell lung cancer patients receiving immune checkpoint inhibitors"],"prefix":"10.1038","volume":"14","author":[{"given":"Martina","family":"Catalano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Fancelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Caliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Mazzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta Gatta","family":"Michelet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Mancini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Manneschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Shabani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brunella","family":"Napolitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Pillozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Antonuzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giandomenico","family":"Roviello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,29]]},"reference":[{"key":"81458_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel Mph","year":"2023","unstructured":"Siegel Mph, R. L. et al. Cancer statistics, 2023. CA. Cancer J. Clin. 73, 17\u201348 (2023).","journal-title":"CA. Cancer J. Clin."},{"key":"81458_CR2","doi-asserted-by":"crossref","unstructured":"Ding, H. et al. Cost effectiveness of immune checkpoint inhibitors for treatment of non-small cell lung cancer: A systematic review. PLoS One 15 (2020).","DOI":"10.1371\/journal.pone.0238536"},{"key":"81458_CR3","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.resinv.2023.10.004","volume":"62","author":"A Tamiya","year":"2024","unstructured":"Tamiya, A. Long-term survival of patients with advanced non-small cell lung cancer treated using immune checkpoint inhibitors. Respir. Investig. 62, 85\u201389 (2024).","journal-title":"Respir. Investig."},{"key":"81458_CR4","doi-asserted-by":"crossref","unstructured":"Rizvi, N. A. et al. Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer. Science 348, 124\u2013128 (2015).","DOI":"10.1126\/science.aaa1348"},{"key":"81458_CR5","doi-asserted-by":"crossref","unstructured":"Aguiar, P. N., De Mello, R. A., Hall, P., Tadokoro, H. & De Lima Lopes, G. PD-L1 expression as a predictive biomarker in advanced non-small-cell lung cancer: Updated survival data. Immunotherapy 9, 499\u2013506 (2017).","DOI":"10.2217\/imt-2016-0150"},{"key":"81458_CR6","doi-asserted-by":"crossref","unstructured":"Shi, T. et al. Cancer immunotherapy: A focus on the regulation of immune checkpoints. Int. J. Mol. Sci. 19, (2018).","DOI":"10.3390\/ijms19051389"},{"key":"81458_CR7","doi-asserted-by":"publisher","first-page":"471","DOI":"10.4149\/318_151001N512","volume":"63","author":"O Fiala","year":"2016","unstructured":"Fiala, O. et al. Serum albumin is a strong predictor of survival in patients with advanced-stage non-small cell lung cancer treated with erlotinib. Neoplasma 63, 471\u2013476 (2016).","journal-title":"Neoplasma"},{"key":"81458_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-016-2610-9","volume":"16","author":"JJ Castillo","year":"2016","unstructured":"Castillo, J. J. et al. The occurrence of hyponatremia and its importance as a prognostic factor in a cross-section of cancer patients. BMC Cancer 16, 1\u20139 (2016).","journal-title":"BMC Cancer"},{"key":"81458_CR9","doi-asserted-by":"publisher","first-page":"23871","DOI":"10.18632\/oncotarget.13372","volume":"8","author":"R Berardi","year":"2017","unstructured":"Berardi, R. et al. Hyponatremia normalization as an independent prognostic factor in patients with advanced non-small cell lung cancer treated with first-line therapy. Oncotarget 8, 23871 (2017).","journal-title":"Oncotarget"},{"key":"81458_CR10","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s11523-018-0599-5","volume":"13","author":"G Fuc\u00e0","year":"2018","unstructured":"Fuc\u00e0, G. et al. Low baseline serum sodium concentration is associated with poor clinical outcomes in metastatic non-small cell lung cancer patients treated with immunotherapy. Target. Oncol. 13, 795\u2013800 (2018).","journal-title":"Target. Oncol."},{"key":"81458_CR11","doi-asserted-by":"publisher","first-page":"651","DOI":"10.21037\/tlcr-20-877","volume":"10","author":"B Sandfeld-Paulsen","year":"2021","unstructured":"Sandfeld-Paulsen, B., Aggerholm-Pedersen, N. & Winther-Larsen, A. Hyponatremia as a prognostic factor in non-small cell lung cancer: A systematic review and meta-analysis. Transl. Lung Cancer Res. 10, 651 (2021).","journal-title":"Transl. Lung Cancer Res."},{"key":"81458_CR12","doi-asserted-by":"publisher","first-page":"197","DOI":"10.5306\/wjco.v5.i3.197","volume":"5","author":"N Kanaji","year":"2014","unstructured":"Kanaji, N. et al. Paraneoplastic syndromes associated with lung cancer. World J. Clin. Oncol. 5, 197\u2013223 (2014).","journal-title":"World J. Clin. Oncol."},{"key":"81458_CR13","doi-asserted-by":"crossref","unstructured":"Ramirez, G. A. et al. Ion channels and transporters in inflammation: Special focus on TRP channels and TRPC6. Cells 7, (2018).","DOI":"10.3390\/cells7070070"},{"key":"81458_CR14","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.cmet.2015.02.003","volume":"21","author":"J Jantsch","year":"2015","unstructured":"Jantsch, J. et al. Cutaneous Na+ storage strengthens the antimicrobial barrier function of the skin and boosts macrophage-driven host defense. Cell Metab. 21, 493\u2013501 (2015).","journal-title":"Cell Metab."},{"key":"81458_CR15","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/s41581-019-0167-y","volume":"15","author":"N Wilck","year":"2019","unstructured":"Wilck, N., Balogh, A., Mark\u00f3, L., Bartolomaeus, H. & M\u00fcller, D. N. The role of sodium in modulating immune cell function. Nat. Rev. Nephrol. 15, 546\u2013558 (2019).","journal-title":"Nat. Rev. Nephrol."},{"key":"81458_CR16","unstructured":"CHMP. Annex I Summary of Product Characteristics."},{"key":"81458_CR17","unstructured":"Summary of product characteristics."},{"key":"81458_CR18","doi-asserted-by":"crossref","unstructured":"Eisenhauer, E. A. et al. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur. J. Cancer 45, 228\u2013247 (2009).","DOI":"10.1016\/j.ejca.2008.10.026"},{"key":"81458_CR19","unstructured":"NIH\/NCI. Common Terminology Criteria for Adverse Events (CTCAE) | Protocol Development | CTEP. Protocol 147 (2017)."},{"key":"81458_CR20","first-page":"1121","volume":"11","author":"A Delgado","year":"2021","unstructured":"Delgado, A. & Guddati, A. K. Clinical endpoints in oncology-a primer. Am J Cancer Res 11, 1121\u20131131 (2021).","journal-title":"Am J Cancer Res"},{"key":"81458_CR21","doi-asserted-by":"publisher","first-page":"e2345185","DOI":"10.1001\/jamanetworkopen.2023.45185","volume":"6","author":"M Catalano","year":"2023","unstructured":"Catalano, M. et al. Sodium Levels and Outcomes in Patients With Metastatic Renal Cell Carcinoma Receiving Nivolumab. JAMA Netw. Open 6, e2345185\u2013e2345185 (2023).","journal-title":"JAMA Netw. Open"},{"key":"81458_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-022-14412-1","volume":"22","author":"D Xiang","year":"2022","unstructured":"Xiang, D. et al. Worldwide cancer statistics of adults over 75 years old in 2019: a systematic analysis of the global burden of disease study 2019. BMC Public Health 22, 1\u201314 (2022).","journal-title":"BMC Public Health"},{"key":"81458_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e29840","volume":"10","author":"S Ni","year":"2024","unstructured":"Ni, S. et al. Prognostic models for immunotherapy in non-small cell lung cancer: A comprehensive review. Heliyon 10, e29840 (2024).","journal-title":"Heliyon"},{"key":"81458_CR25","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1007\/s00520-018-4489-2","volume":"27","author":"S Rinaldi","year":"2019","unstructured":"Rinaldi, S. et al. The prognostic and predictive role of hyponatremia in patients with advanced non-small cell lung cancer (NSCLC) with bone metastases. Support. Care Cancer 27, 1255\u20131261 (2019).","journal-title":"Support. Care Cancer"},{"key":"81458_CR26","doi-asserted-by":"publisher","first-page":"1361010","DOI":"10.3389\/fimmu.2024.1361010","volume":"15","author":"M Catalano","year":"2024","unstructured":"Catalano, M. et al. Sodium levels and immunotherapy efficacy in mRCC patients with bone metastases: sub analysis of Meet-Uro 15 study. Front. Immunol. 15, 1361010 (2024).","journal-title":"Front. Immunol."},{"key":"81458_CR27","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1161\/HYPERTENSIONAHA.123.19489","volume":"81","author":"H Miyauchi","year":"2024","unstructured":"Miyauchi, H. et al. Sodium as an Important Regulator of Immunometabolism. Hypertension 81, 426\u2013435 (2024).","journal-title":"Hypertension"},{"key":"81458_CR28","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.3389\/fimmu.2019.01141","volume":"10","author":"R Willebrand","year":"2019","unstructured":"Willebrand, R. et al. High salt inhibits tumor growth by enhancing anti-tumor immunity. Front. Immunol. 10, 1141 (2019).","journal-title":"Front. Immunol."},{"key":"81458_CR29","doi-asserted-by":"crossref","unstructured":"He, W. et al. High-salt diet inhibits tumour growth in mice via regulating myeloid-derived suppressor cell differentiation. Nat. Commun. 11, (2020).","DOI":"10.1038\/s41467-020-15524-1"},{"key":"81458_CR30","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1038\/cr.2015.87","volume":"25","author":"WC Zhang","year":"2015","unstructured":"Zhang, W. C. et al. High salt primes a specific activation state of macrophages, M(Na). Cell Res. 25, 893\u2013910 (2015).","journal-title":"Cell Res."},{"key":"81458_CR31","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/s41577-018-0113-4","volume":"19","author":"DN M\u00fcller","year":"2019","unstructured":"M\u00fcller, D. N., Wilck, N., Haase, S., Kleinewietfeld, M. & Linker, R. A. Sodium in the microenvironment regulates immune responses and tissue homeostasis. Nat. Rev. Immunol. 19, 243\u2013254 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"81458_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.918413","author":"G Roviello","year":"2022","unstructured":"Roviello, G. et al. Prognostic value of normal sodium levels in patients with metastatic renal cell carcinoma receiving tyrosine kinase inhibitors OPEN ACCESS. Front. Oncol. Front. https:\/\/doi.org\/10.3389\/fonc.2022.918413 (2022).","journal-title":"Front. Oncol. Front."},{"key":"81458_CR33","doi-asserted-by":"publisher","first-page":"2345185","DOI":"10.1001\/jamanetworkopen.2023.45185","volume":"6","author":"M Catalano","year":"2023","unstructured":"Catalano, M. et al. Sodium Levels and Outcomes in Patients With Metastatic Renal Cell Carcinoma Receiving Nivolumab + Supplemental content. JAMA Netw. Open 6, 2345185 (2023).","journal-title":"JAMA Netw. Open"},{"key":"81458_CR34","unstructured":"Rossi, F. et al. Gender oncology: differences in epidemiology, clinical outcome and toxicity in the two sexes. A narrative review. J. Sex- Gender-Specific Med. 9, 130\u2013142 (2023)."},{"key":"81458_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.critrevonc.2015.04.005","volume":"96","author":"C Groh\u00e9","year":"2015","unstructured":"Groh\u00e9, C., Berardi, R. & Burst, V. Hyponatraemia\u2013SIADH in lung cancer diagnostic and treatment algorithms. Crit. Rev. Oncol. Hematol. 96, 1\u20138 (2015).","journal-title":"Crit. Rev. Oncol. Hematol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81458-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81458-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81458-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T03:03:23Z","timestamp":1732849403000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81458-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,29]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["81458"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-81458-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,29]]},"assertion":[{"value":"26 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"29655"}}